162 related articles for article (PubMed ID: 3575347)
1. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
Gordon JH; Clopton JK; Curtin JC; Koller WC
Pharmacol Biochem Behav; 1987 Feb; 26(2):223-8. PubMed ID: 3575347
[TBL] [Abstract][Full Text] [Related]
2. Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.
Kendler KS; Bracha HS; Davis KL
Eur J Pharmacol; 1982 Apr; 79(3-4):217-23. PubMed ID: 6124428
[TBL] [Abstract][Full Text] [Related]
3. Behavioral evidence for dopamine receptor subsensitivity following chronic haloperidol.
Lynch MR
Neuropsychobiology; 1990-1991; 24(2):102-8. PubMed ID: 2151972
[TBL] [Abstract][Full Text] [Related]
4. Differential enhancement of behavioral sensitivity to apomorphine following chronic treatment of rats with (-)-sulpiride and haloperidol.
Montanaro N; Dall'Olio R; Gandolfi O; Vaccheri A
Eur J Pharmacol; 1982 Jun; 81(1):1-9. PubMed ID: 6889533
[TBL] [Abstract][Full Text] [Related]
5. Changes in apomorphine-induced stereotypy as a result of subacute neuroleptic treatment correlates with increased D-2 receptors, but not with increases in D-1 receptors.
Fleminger S; Rupniak NM; Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2921-7. PubMed ID: 6138043
[TBL] [Abstract][Full Text] [Related]
6. Effect of daily dose of chronic haloperidol and chronic apomorphine on behavioral hypersensitivity in the rat.
Kinon BJ; Merson D; Kane JM
Psychopharmacology (Berl); 1984; 84(3):347-51. PubMed ID: 6440181
[TBL] [Abstract][Full Text] [Related]
7. Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.
Morgenstern R; Fink H
J Neural Transm; 1985; 61(3-4):151-60. PubMed ID: 3989521
[TBL] [Abstract][Full Text] [Related]
8. Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.
Alander T; Andén NE; Grabowska-Andén M
Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):145-50. PubMed ID: 7402361
[TBL] [Abstract][Full Text] [Related]
9. Drug effects on pre- and postsynaptic dopamine receptors.
Andén NE; Grabowska-Andén M
Adv Biochem Psychopharmacol; 1980; 24():57-64. PubMed ID: 6105802
[No Abstract] [Full Text] [Related]
10. Pharmacologic evaluation of dopaminergic receptor blockade by metoclopramide.
Hassan MN; Reches A; Kuhn C; Higgins D; Fahn S
Clin Neuropharmacol; 1986; 9(1):71-8. PubMed ID: 3829008
[TBL] [Abstract][Full Text] [Related]
11. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
[TBL] [Abstract][Full Text] [Related]
12. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
Yasuda Y; Kikuchi T; Suzuki S; Tsutsui M; Yamada K; Hiyama T
Life Sci; 1988; 42(20):1941-54. PubMed ID: 3130534
[TBL] [Abstract][Full Text] [Related]
13. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
De Veaugh-Geiss J; Devanand DP; Carey RJ
Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
[TBL] [Abstract][Full Text] [Related]
14. Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Bartoszyk GD; Harting J; Minck KO
J Pharmacol Exp Ther; 1996 Jan; 276(1):41-8. PubMed ID: 8558454
[TBL] [Abstract][Full Text] [Related]
15. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
Nowak JZ; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
[TBL] [Abstract][Full Text] [Related]
16. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.
Prosser ES; Pruthi R; Csernansky JG
Psychopharmacology (Berl); 1989; 99(1):109-16. PubMed ID: 2506596
[TBL] [Abstract][Full Text] [Related]
17. Sulpiride injection into the dorsal striatum increases methamphetamine-induced gnawing in rats.
Koshikawa N; Aoki S; Tomiyama K; Maruyama Y; Kobayashi M
Eur J Pharmacol; 1987 Jan; 133(1):119-25. PubMed ID: 3556388
[TBL] [Abstract][Full Text] [Related]
18. The effects of some atypical neuroleptics on apomorphine-induced behaviors as a measure of their relative potencies in blocking presynaptic versus postsynaptic dopamine receptors.
Robertson A; MacDonald C
Pharmacol Biochem Behav; 1986 Jun; 24(6):1639-43. PubMed ID: 2874567
[TBL] [Abstract][Full Text] [Related]
19. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors.
Hietala J; MacDonald E; Scheinin M
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):291-7. PubMed ID: 3799208
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D-2 antagonists reverse apomorphine-induced decreased water intake in the rat: prediction of antipsychotic drugs with few extrapyramidal side-effects?
Ljungberg T
J Neural Transm; 1989; 76(2):79-90. PubMed ID: 2565360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]